ULIVELLI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 8.789
EU - Europa 7.312
AS - Asia 3.817
SA - Sud America 711
AF - Africa 286
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 12
Totale 20.945
Nazione #
US - Stati Uniti d'America 8.645
GB - Regno Unito 2.009
RU - Federazione Russa 1.351
SG - Singapore 1.291
CN - Cina 1.268
IE - Irlanda 926
IT - Italia 907
BR - Brasile 580
SE - Svezia 515
UA - Ucraina 450
FR - Francia 388
VN - Vietnam 333
DE - Germania 323
HK - Hong Kong 292
KR - Corea 181
FI - Finlandia 176
ZA - Sudafrica 135
IN - India 96
TR - Turchia 87
CA - Canada 63
ES - Italia 53
MX - Messico 53
NL - Olanda 51
AR - Argentina 45
CI - Costa d'Avorio 45
NG - Nigeria 45
IQ - Iraq 40
BD - Bangladesh 37
PL - Polonia 35
AT - Austria 31
BE - Belgio 24
SA - Arabia Saudita 24
EC - Ecuador 21
PK - Pakistan 21
JP - Giappone 20
VE - Venezuela 19
AU - Australia 16
CL - Cile 13
AE - Emirati Arabi Uniti 12
MA - Marocco 12
PH - Filippine 12
KE - Kenya 11
KZ - Kazakistan 11
CO - Colombia 10
UZ - Uzbekistan 10
DZ - Algeria 9
ID - Indonesia 9
PE - Perù 9
CZ - Repubblica Ceca 8
LB - Libano 8
LT - Lituania 8
NP - Nepal 8
EU - Europa 7
GR - Grecia 7
IL - Israele 7
JM - Giamaica 7
JO - Giordania 7
MY - Malesia 7
PY - Paraguay 7
RO - Romania 7
AL - Albania 6
PA - Panama 6
SN - Senegal 6
TN - Tunisia 6
EG - Egitto 5
MN - Mongolia 5
OM - Oman 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GE - Georgia 4
IR - Iran 4
LV - Lettonia 4
RS - Serbia 4
UY - Uruguay 4
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NO - Norvegia 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BW - Botswana 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
NI - Nicaragua 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 20.929
Città #
Southend 1.830
Fairfield 976
Dublin 914
Dallas 903
Ashburn 690
Singapore 673
Chandler 522
Woodbridge 452
Santa Clara 451
Wilmington 393
Jacksonville 367
Moscow 366
Houston 344
Cambridge 341
Seattle 338
Beijing 328
Hong Kong 276
Ann Arbor 243
Hefei 232
San Jose 228
Siena 202
Seoul 181
Princeton 159
The Dalles 154
Menlo Park 138
Johannesburg 127
Nanjing 115
Los Angeles 109
Milan 106
Ho Chi Minh City 95
Council Bluffs 94
Lauterbourg 88
Helsinki 87
New York 74
Florence 70
Hanoi 63
Dong Ket 61
Munich 61
San Diego 61
Boardman 60
San Mateo 55
São Paulo 54
Buffalo 53
Dearborn 50
Abidjan 45
Nanchang 44
Izmir 42
Shanghai 42
Orem 41
Rome 41
Abuja 40
London 39
Columbus 37
Norwalk 37
Tianjin 34
Málaga 31
Redondo Beach 31
Shenyang 27
Warsaw 27
Bengaluru 25
San Francisco 25
Brussels 24
Nuremberg 24
Jinan 23
Amsterdam 22
Frankfurt am Main 21
Rio de Janeiro 21
Triggiano 20
Vienna 20
Changsha 19
Mexico City 19
Belo Horizonte 18
Chicago 18
Fremont 18
Guangzhou 17
Tokyo 17
Turku 17
Denver 16
Düsseldorf 16
Stockholm 16
Ankara 15
Brooklyn 15
Kunming 15
Lappeenranta 15
Toronto 15
Boston 14
Chennai 14
Da Nang 14
Ottawa 14
Washington 13
Zhengzhou 13
Baghdad 12
Haiphong 12
Jiaxing 12
Hebei 11
Montreal 11
North Bergen 11
Phoenix 11
Prato 11
Quito 11
Totale 14.417
Nome #
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 423
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 323
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 310
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 297
Multiple sclerosis incidence in Tuscany from administrative data 297
Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery 292
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 271
Multiple sclerosis spatial cluster in Tuscany 271
Multiple sclerosis incidence in Tuscany from administrative data 262
Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants 261
Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients 256
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 253
Citalopram as treatment of depression in patients with epilepsy 250
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. 245
A clinically silent, but severe, duodenal complication of duodopa infusion 245
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 245
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 244
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 242
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 240
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 240
Increasing prevalence of multiple sclerosis in Tuscany, Italy 236
The Italian Multiple Sclerosis Register 233
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 233
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study 232
Clinical evidence of fluconazole-induced carbamazepine toxicity 231
The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna 231
CAT and MRI in the study of partial epilepsy: comparison of the 2 methods and correlations with EEG [TAC e RMN nello studio delle epilessie parziali: confronto tra le due metodiche e correlazioni con l'EEG] 230
Carbamazepine and carbamazepine-epoxide plasma levels during lamotrigine add-on [Livelli plasmatici di carbamazepina e carbamazepina epossido dopo add-on di lamotrigina] 229
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 227
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 227
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 227
Antiparkinsonian drugs and visual hallucinations 225
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 225
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 223
Association of celiac disease in patients with multiple sclerosis in Tuscany 222
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications 221
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 221
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 220
La distribuzione geografica della sclerosi multipla in Toscana 217
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. 217
A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS) 216
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 209
Distinct olfactory cross-modal effects on the human motor system 208
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 203
Emerging of new bioartificial corticospinal motor synergies using a robotic additional thumb 202
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 201
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 199
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 198
Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study 198
Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans 198
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 198
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study 194
The heart side of brain neuromodulation 194
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 194
Reliability of administrative data for the identification of Parkinson's disease cohorts 192
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 191
Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies 190
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study 188
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) 187
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 185
The olfactory side of Parkinson disease: Relevance for clinical practice 184
Feasibility of TMS in patients with new generation cochlear implants 184
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial 183
Primary intraventricular haemorrhage in adults 182
Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome 179
Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients" 179
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study 178
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures 178
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression 177
Seizures after spontaneous supratentorial intracerebral hemorrhage 176
Somatosensory processing during movement observation in humans 176
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test 176
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study 175
Mortality of Parkinson’s disease in Italy from 1980 to 2015 175
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 174
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 172
Modulation of high-frequency (600 Hz) somatosensory-evoked potentials after rTMS of the primary sensory cortex 170
Mortality of Alzheimer’s disease in Italy from 1980 to 2015 169
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy 169
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 169
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 167
rTMS for PTSD: induced merciful oblivion or elimination of abnormal hypermnesia? 162
Temporal dynamics of memory trace formation in the human prefrontal cortex 162
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 162
Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls 161
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease 159
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 155
Reduction of cortical myoclonus-related epileptic activity following slow-frequency rTMS 152
Quantitative analysis of Lamotrigine in plasma and tablets by planar chromatography and comparison with liquid 147
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 136
Uveitis: A snapshot in the MOG antibody spectrum 136
Prospective study of clinical, neurophysiological and urodynamic findings in multiple scleosis patients undergoing percutaneous transluminal venous angioplasty 133
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 131
Human ventral parietal cortex plays a functional role on visuospatial attention and primary consciousness. A repetitive transcranial magnetic stimulation study 131
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 130
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 125
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 124
Does Risk of Hyperhomocysteinemia Depend on Thiol-Disulfide Exchange Reactions of Albumin and Homocysteine? 123
Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients 122
Pisa syndrome in Parkinson disease 122
Totale 20.304
Categoria #
all - tutte 63.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021529 0 0 0 0 0 0 0 0 0 170 181 178
2021/20221.480 97 179 106 89 141 70 78 52 100 143 152 273
2022/20231.943 114 191 280 250 163 369 52 177 192 48 70 37
2023/20241.408 64 27 116 82 42 362 485 55 13 21 43 98
2024/20253.083 57 163 271 174 399 182 148 196 282 122 333 756
2025/20266.268 505 940 772 770 1.226 285 783 281 289 417 0 0
Totale 21.242